Skip to content
2000
Volume 15, Issue 14
  • ISSN: 1567-2050
  • E-ISSN: 1875-5828

Abstract

The pathogenic mechanisms of Alzheimer's Disease (AD) involve the deposition of abnormally misfolded proteins, amyloid β protein (Aβ) and tau protein. Aβ comprises senile plaques, and tau aggregates form Neurofibrillary Tangles (NFTs), both of which are hallmarks of AD. Autophagy is the main conserved pathway for the degeneration of aggregated proteins, Aβ, tau and dysfunctional organelles in the cell. Many animal model studies have demonstrated that autophagy normally functions as the protective factor against AD progression associated with intracytoplasmic toxic Aβ and tau aggregates. The upregulation of autophagy can also be favorable in AD treatment. An improved understanding of the signaling pathways that regulate autophagy is critical to developing AD treatments. The cellular and molecular machineries of autophagy, their function in the pathogenesis of AD, and current drug discovery strategies will be discussed in this review.

Loading

Article metrics loading...

/content/journals/car/10.2174/1567205015666181004143432
2018-12-01
2025-06-16
Loading full text...

Full text loading...

/content/journals/car/10.2174/1567205015666181004143432
Loading

  • Article Type:
    Review Article
Keyword(s): Alzheimer's disease; amyloid β protein; autophagosome; autophagy; tau; therapy
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test